
Rani Therapeutics Forms Golden Cross, Signaling Potential Bullish Breakout
2025-11-07 15:24:44Rani Therapeutics Holdings, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. Current technical indicators present a mixed outlook, with bullish daily moving averages and a bearish weekly RSI. Despite a one-year decline, the stock has surged 349.5% over the past month, outperforming the S&P 500.
Read More
Rani Therapeutics Hits New 52-Week High of $3.87, Marking Major Milestone
2025-10-23 17:15:17Rani Therapeutics Holdings, Inc. achieved a new 52-week high of USD 3.87 on October 22, 2025, despite facing a challenging year with a significant decline in performance. The company operates in the Pharmaceuticals & Biotechnology sector and has notable financial metrics, including a high return on equity.
Read MoreIs Rani Therapeutics Holdings, Inc. technically bullish or bearish?
2025-09-20 20:22:06As of 1 July 2025, the technical trend for Rani Therapeutics Holdings, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a mix of indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI shows a bullish signal on the monthly but no signal on the weekly. However, moving averages are bearish on the daily, and Bollinger Bands are bearish on both weekly and monthly time frames. KST is mildly bullish weekly but bearish monthly, and Dow Theory indicates a mildly bullish stance monthly with no trend weekly. In terms of performance, the stock has significantly underperformed compared to the S&P 500 across all periods, with a year-to-date return of -64.85% versus the S&P 500's 12.22%, and a one-year return of -79.06% compared to 17.14% for the index....
Read More





